Treatment Characteristics and Determinants of Poor Glycaemic Control among Type 2 Diabetes Mellitus (T2DM) Patients Attending Clinics at the Three Selected Health Centres in Suva, Fiji between 2011 a 2016

α
Pablo C. Romakin
Pablo C. Romakin
σ
Masoud Mohammadnezhad
Masoud Mohammadnezhad
ρ
Donald Wilson
Donald Wilson
Ѡ
Sabiha Khan
Sabiha Khan
α Fiji National University

Send Message

To: Author

Treatment Characteristics and Determinants of Poor Glycaemic Control among Type 2 Diabetes Mellitus (T2DM) Patients Attending Clinics at the Three Selected Health Centres in Suva, Fiji between 2011 a 2016

Article Fingerprint

ReserarchID

SM5N8

Treatment Characteristics and Determinants of Poor Glycaemic Control among Type 2 Diabetes Mellitus (T2DM) Patients Attending Clinics at the Three Selected Health Centres in Suva, Fiji between 2011 a 2016 Banner

AI TAKEAWAY

Connecting with the Eternal Ground
  • English
  • Afrikaans
  • Albanian
  • Amharic
  • Arabic
  • Armenian
  • Azerbaijani
  • Basque
  • Belarusian
  • Bengali
  • Bosnian
  • Bulgarian
  • Catalan
  • Cebuano
  • Chichewa
  • Chinese (Simplified)
  • Chinese (Traditional)
  • Corsican
  • Croatian
  • Czech
  • Danish
  • Dutch
  • Esperanto
  • Estonian
  • Filipino
  • Finnish
  • French
  • Frisian
  • Galician
  • Georgian
  • German
  • Greek
  • Gujarati
  • Haitian Creole
  • Hausa
  • Hawaiian
  • Hebrew
  • Hindi
  • Hmong
  • Hungarian
  • Icelandic
  • Igbo
  • Indonesian
  • Irish
  • Italian
  • Japanese
  • Javanese
  • Kannada
  • Kazakh
  • Khmer
  • Korean
  • Kurdish (Kurmanji)
  • Kyrgyz
  • Lao
  • Latin
  • Latvian
  • Lithuanian
  • Luxembourgish
  • Macedonian
  • Malagasy
  • Malay
  • Malayalam
  • Maltese
  • Maori
  • Marathi
  • Mongolian
  • Myanmar (Burmese)
  • Nepali
  • Norwegian
  • Pashto
  • Persian
  • Polish
  • Portuguese
  • Punjabi
  • Romanian
  • Russian
  • Samoan
  • Scots Gaelic
  • Serbian
  • Sesotho
  • Shona
  • Sindhi
  • Sinhala
  • Slovak
  • Slovenian
  • Somali
  • Spanish
  • Sundanese
  • Swahili
  • Swedish
  • Tajik
  • Tamil
  • Telugu
  • Thai
  • Turkish
  • Ukrainian
  • Urdu
  • Uzbek
  • Vietnamese
  • Welsh
  • Xhosa
  • Yiddish
  • Yoruba
  • Zulu

Abstract

Introduction and Aim: Type 2 Diabetes Mellitus (T2DM) is a global health problem that is reaching epidemic proportions. It Fiji, it has a high admission rate due to complications and is the number one cause of disease specific mortality. The aim of this study was to determine the proportion of poor glycaemic control level among adult T2DM patients, their treatment characteristics and determinants. Methods: This was a 5-year retrospective medical folder audit on randomly selected folders registered between August 1, 2011 to August 1, 2016 from the three selected health centres in Suva, Fiji who all met the following inclusion criteria: T2DM adults > 18 years old, has recent HbA1c test result in 2017, on treatment for > one year and > 4 clinic visits. A total sample of 338 was derived out of 2,073 T2DM registered during the 5-year period and was calculated using proportionate sampling method. The most recent HbA1c was the parameter used to measure glycaemic control. Logistic regression analysis in SPSS version 22 was used to assess the effect of patient’s treatment determinants on glycaemic control with p< .05 considered as significant.

References

34 Cites in Article
  1. (2018). Standards of medical care in diabetes-2018.
  2. G Bruno,C Runzo,P Cavallo-Perin (2005). Incidence of Type 1 and Type 2 Diabetes in Adults Aged 30-49 Years: The population-based registry in the province of Turin, Italy.
  3. N Holman,B Young,R Gadsby (2015). Current prevalence of Type 1 and Type 2 diabetes in adults and children in the <scp>UK</scp>.
  4. (2017). International Diabetes Federation Eighth edition.
  5. S Tin,C Lee,R Colagiuri (2015). A profile of diabetes in Pacific Island Countries and Territories.
  6. Stephen Morrell,Sophia Lin,Isimeli Tukana,Christine Linhart,Richard Taylor,Penina Vatucawaqa,Dianna Magliano,Paul Zimmet (2016). Diabetes incidence and projections from prevalence surveys in Fiji.
  7. S Lin,I Tukana,C Linhart,S Morrel,R Taylor,P Vatucawaqa (2016). Diabetes and obesity trends in Fiji over 30 years.
  8. Zubin Punthakee,Ronald Goldenberg,Pamela Katz (2018). Definition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome.
  9. J Karalliedde,L Gnudi (2016). Diabetes mellitus, a complex and heterogeneous disease, and the role of insulin resistance as a determinant of diabetic kidney disease.
  10. K Alberti,P Zimmet (2006). Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation.
  11. Pablo Aschner (2017). New IDF clinical practice recommendations for managing type 2 diabetes in primary care.
  12. A Nanditha,A Ramachandran,S Chamukuttan,J Chand,K Chia,J Shaw,P Zimmet (2016). Diabetes in Asia and the Pacific: implications for the global epidemic.
  13. Khalid Alnairi,Sujoud Ghallab,Fatima Alslail,Kawther Abdelfadil,Sahar Fadil,Ibtihal Jumah,Amal Almutairy,Deemah Alfadhli,Sumaiya Alamri,Abdulaziz S. Almeshal (2002). GLYCAEMIC CONTROL AMONG SAUDI PATIENTS WITH TYPE 2 DIABETES MELLITUS AT FIRST TIME REGISTRY IN RAQEB RECORDS FROM 2018-2022.
  14. Amir Qaseem,Roger Chou,Linda Humphrey,Paul Shekelle,Paul Shekelle,Roger Chou,Paul Dallas,Thomas Denberg,Nick Fitterman,Mary Ann Forciea,Robert Hopkins,Linda Humphrey,Tanveer Mir,Holger Schünemann,Donna Sweet,David Weinberg (2012). Inpatient Glycemic Control.
  15. L Ryden,E Standl,M Bartnik,G Van Den Berghe,J Betteridge,M-J De Boer,F Cosentino,B Jonsson,M Laakso,K Malmberg,S Priori,J Ostergren,J Tuomilehto,I Thrainsdottir,I Vanhorebeek,M Stramba-Badiale,P Lindgren,Q Qiao,S Priori,J-J Blanc,A Budaj,J Camm,V Dean,J Deckers,K Dickstein,J Lekakis,K Mcgregor,M Metra,J Morais,A Osterspey,J Tamargo,J Zamorano,J Deckers,M Bertrand,B Charbonnel,E Erdmann,E Ferrannini,A Flyvbjerg,H Gohlke,J Juanatey,I Graham,P Monteiro,K Parhofer,K Pyorala,I Raz,G Schernthaner,M Volpe,D Wood (2007). Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD).
  16. B Nayal,C Raghuveer,N Suvarna,Gbk Manjunatha,D Sarsina,R Devaki (2011). International Journal of Pharmaceutical Sciences Review and Research.
  17. I Stratton,A Adler,H Neil,D Matthews,S Manley,C Cull (2000). Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.
  18. Ronald Klein,Barbara Klein (1998). Relation of Glycemic Control to Diabetic Complications and Health Outcomes.
  19. K Kumar,W Snowdon,S Ram,S Khan,M Cornelius,I Tukana,S Reid (2014). Descriptive analysis of diabetes-related amputations at the Colonial War Memorial Hospital, Fiji, 2010–2012.
  20. Liou Jyun‐you,Mu Chia‐fen,Hsu Chao‐yu (2012). Medical appointment no‐shows associated with poor glycaemic control among <scp>T</scp>aiwanese aborigines.
  21. Salwa Abougalambou,Nahid Ahmed,Ayman Abougalambou (2015). A study evaluating the postprandial plasma glucose control among type 2 diabetes patients attending a teaching hospital in Malaysia.
  22. G Timothy (2010). Factors influencing glycaemic control in diabetics at three community health centres in Johannesburg.
  23. Del Prato,S Felton,A Munro,N Nesto,R Zimmet,P Zinman,B (2005). Improving glucose management: ten steps to get more patients with type 2 diabetes to glycaemic goal.
  24. Ahmad Islahudin,F Paraidathathu,T (2014). Factors associated with good glycemic control among patients with type 2 diabetes mellitus.
  25. H Huri,D Ling,W Ahmad (2015). Association between glycemic control and antidiabetic drugs in type 2 diabetes mellitus patients with cardiovascular complications.
  26. Pedro De Pablos‐velasco,Klaus Parhofer,Clare Bradley,Eveline Eschwège,Linda Gönder-Frederick,Pierre Maheux,Ian Wood,Dominique Simon (2014). Current level of glycaemic control and its associated factors in patients with type 2 diabetes across Europe: data from the PANORAMA study.
  27. Leonardo Sechi,Cristiana Catena,Laura Zingaro,Alessandra Melis,Sergio De Marchi (2002). Abnormalities of Glucose Metabolism in Patients With Early Renal Failure.
  28. Deborah Juarez,Tetine Sentell,Sheri Tokumaru,Roy Goo,James Davis,Marjorie Mau (2012). Factors Associated With Poor Glycemic Control or Wide Glycemic Variability Among Diabetes Patients in Hawaii, 2006–2009.
  29. Martin Busch,Jennifer Nadal,Matthias Schmid,Katharina Paul,Stephanie Titze,Silvia Hübner,Anna Köttgen,Ulla Schultheiss,Seema Baid-Agrawal,Johan Lorenzen,Georg Schlieper,Claudia Sommerer,Vera Krane,Robert Hilge,Jan Kielstein,Florian Kronenberg,Christoph Wanner,Kai-Uwe Eckardt,Gunter Wolf (2016). Glycaemic control and antidiabetic therapy in patients with diabetes mellitus and chronic kidney disease – cross-sectional data from the German Chronic Kidney Disease (GCKD) cohort.
  30. Richard Grant,Nicole Devita,Daniel Singer,James Meigs (2003). Polypharmacy and Medication Adherence in Patients With Type 2 Diabetes.
  31. J Vietri,C Wlodarczyk,R Lorenzo,S Rajpathak (2016). Missed doses of oral anti-hyperglycemic medications in US adults with type 2 diabetes mellitus: prevalence and self-reported reasons.
  32. F Chung,A Herceg,M Bookallil (2014). Diabetes clinic attendance improves diabetes management in an urban Aboriginal and Torres Strait Islander population.
  33. Craig Currie,Mark Peyrot,Christopher Morgan,Chris Poole,Sara Jenkins-Jones,Richard Rubin,Christopher Burton,Marc Evans (2012). The Impact of Treatment Noncompliance on Mortality in People With Type 2 Diabetes.
  34. Elizabeth Pulgarón,Jennifer Hernandez,Heather Dehaan,Anna Patiño-Fernandez,Adriana Carrillo,Janine Sanchez,Alan Delamater (2015). Clinic attendance and health outcomes of youth with type 2 diabetes mellitus.

Funding

No external funding was declared for this work.

Conflict of Interest

The authors declare no conflict of interest.

Ethical Approval

No ethics committee approval was required for this article type.

Data Availability

Not applicable for this article.

How to Cite This Article

Pablo C. Romakin. 2018. \u201cTreatment Characteristics and Determinants of Poor Glycaemic Control among Type 2 Diabetes Mellitus (T2DM) Patients Attending Clinics at the Three Selected Health Centres in Suva, Fiji between 2011 a 2016\u201d. Global Journal of Medical Research - F: Diseases GJMR-F Volume 18 (GJMR Volume 18 Issue F3): .

Download Citation

Journal Specifications

Crossref Journal DOI 10.17406/gjmra

Print ISSN 0975-5888

e-ISSN 2249-4618

Keywords
Classification
GJMR-F Classification: NLMC Code: WD 200.5.G6
Version of record

v1.2

Issue date

August 27, 2018

Language
en
Experiance in AR

Explore published articles in an immersive Augmented Reality environment. Our platform converts research papers into interactive 3D books, allowing readers to view and interact with content using AR and VR compatible devices.

Read in 3D

Your published article is automatically converted into a realistic 3D book. Flip through pages and read research papers in a more engaging and interactive format.

Article Matrices
Total Views: 3065
Total Downloads: 1552
2026 Trends
Related Research

Published Article

Introduction and Aim: Type 2 Diabetes Mellitus (T2DM) is a global health problem that is reaching epidemic proportions. It Fiji, it has a high admission rate due to complications and is the number one cause of disease specific mortality. The aim of this study was to determine the proportion of poor glycaemic control level among adult T2DM patients, their treatment characteristics and determinants. Methods: This was a 5-year retrospective medical folder audit on randomly selected folders registered between August 1, 2011 to August 1, 2016 from the three selected health centres in Suva, Fiji who all met the following inclusion criteria: T2DM adults > 18 years old, has recent HbA1c test result in 2017, on treatment for > one year and > 4 clinic visits. A total sample of 338 was derived out of 2,073 T2DM registered during the 5-year period and was calculated using proportionate sampling method. The most recent HbA1c was the parameter used to measure glycaemic control. Logistic regression analysis in SPSS version 22 was used to assess the effect of patient’s treatment determinants on glycaemic control with p< .05 considered as significant.

Our website is actively being updated, and changes may occur frequently. Please clear your browser cache if needed. For feedback or error reporting, please email [email protected]

Request Access

Please fill out the form below to request access to this research paper. Your request will be reviewed by the editorial or author team.
X

Quote and Order Details

Contact Person

Invoice Address

Notes or Comments

This is the heading

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

High-quality academic research articles on global topics and journals.

Treatment Characteristics and Determinants of Poor Glycaemic Control among Type 2 Diabetes Mellitus (T2DM) Patients Attending Clinics at the Three Selected Health Centres in Suva, Fiji between 2011 a 2016

Pablo C. Romakin
Pablo C. Romakin Fiji National University
Masoud Mohammadnezhad
Masoud Mohammadnezhad
Donald Wilson
Donald Wilson
Sabiha Khan
Sabiha Khan

Research Journals